NMD4C Honored with Dr David Green Award for Excellence in Service Delivery at MDC Awards Gala
In April of 2024 we shared the exciting news that our network had been awarded one of the prestigious Dr David Green Awards from Muscular Dystrophy Canada (MDC), and last week Dr Jodi Warman-Chardon accepted the Dr David Green Excellence in Service Delivery Award on behalf of the network at the annual MDC Awards Gala.
Dr Warman-Chardon highlighted the many collaborative successes of the network to date, emphasizing our training and education initiatives that ensure the next generation of neuromuscular clinicians and researchers are well-prepared to meet the challenges of NMDs; and our patient partner training initiatives, developing online training modules to help patients take the first steps towards becoming trained patient partners, and researchers to become familiar with the research environment as it relates to patient engagement and take the first steps towards working with patient partners.
We are honored to receive the Excellence in Service Delivery Award for 2024 and are excited to continue working with MDC and the entire Canadian neuromuscular community towards our network mission to improve the care, research, and treatment of NMDs for all Canadians.
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.